Change in the hepatic profile of hepatitis C virus genotype 4 –infected patients with compensated cirrhosis receiving ombitasvir, paritaprevir, and ritonavir plus ribavirin: A subanalysis of the AGATE‐II study

Journal of Medical Virology, EarlyView.

Source: Journal of Medical Virology - July 16, 2018 Category: Virology Authors: ImamWaked MD , GamalEsmat , RababFouad , NaglaaAllam , MohamedHassany , MohammadMohey , GamalShiha , RehamSoliman , Roula B.Qaqish , ColeenHall , Negar N.Alami , SarahKopecky ‐Bromberg , NiloufarMobashery Source Type: research